Kepler K2 "Bumblebee" Debuts at ICRA 2025, Captivating Attendees
ATLANTA, June 3, 2025 /PRNewswire/ -- During the IEEE International Conference on Robotics and Automation 2025 (ICRA 2025) held in Atlanta from May 19 to 23, Shanghai Kepler Robotics Co., Ltd ("Kepler Humanoid Robot") introduced its latest...
Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025
BEIJING, June 3, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising...
XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS
SUZHOU, China, June 3, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has received seven...
2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer
YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a Phase 2 clinical study conducted in China evaluating...
Taoping Selected for New US$2.8 Million Agricultural Product Supply Contract; Company Continues to Build Momentum in Important Growth Market
SHENZHEN, China, June 2, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that it has been selected for a new RMB 20 million (US$2.8 million) sales...
InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...
Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session
NANJING, China, May 31, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a multicenter phase Ib/II clinical trial evaluating LBL-024, an anti-PD-L1/4-1BB...
Arctech to Supply 175 MW of Solar Trackers for Landmark Green Hydrogen Project in Oman
DUQM, Oman, May 31, 2025 /PRNewswire/ -- Arctech, the global leader in solar tracking, racking, and BIPV solutions, has signed a strategic contract with ACME Cleantech Solutions Pvt. Ltd. a pure play fully integrated Renewable Energy Company in...
Wang Lao Ji (WALOVI) Showcases at ASEAN-GCC-China Economic Forum, Plans Localized Production in Malaysia
KUALA LUMPUR, Malaysia, May 30, 2025 /PRNewswire/ -- Guangzhou Pharmaceutical Holdings Limited (GPHL), a Fortune Global 500 company, has taken a significant step forward in its global collaboration efforts. From May 27, the ASEAN-GCC-China Economic...
Highreso Announces Discount Plans for NVIDIA H200-equipped GPUSOROBAN-AI SPACON Cloud and Begins Accepting Reservations for NVIDIA B200
TOKYO, May 30, 2025 /PRNewswire/ -- Highreso Co., Ltd. has announced discount plans for its NVIDIA H200-equipped GPUSOROBAN-AI SPACON Cloud. GPUSOROBAN is a low-price cloud platform for GPU computing offered with a simple pricing system. The use of...